(Q45980565)
Statements
1 reference
Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial. (English)
1 reference
Gerd Plewig
1 reference
William J Cunliffe
1 reference
Natascha Binder
1 reference
Kornelia Höschen
1 reference
9 May 2009
1 reference
1 reference
80
1 reference
1
1 reference
25-33
1 reference
Identifiers
1 reference